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Central memory T cell (Tcm) and polyfunctional CD4 T cell responses contribute to
vaccine-elicited protection with both human and bovine tuberculosis (TB); however, their 
combined role in protective immunity to TB is unclear. To address this question, we eval-
uated polyfunctional cytokine responses by CD4 T cell effector/memory populations from 
bacille Calmette–Guerin (BCG) vaccinated and non-vaccinated calves by flow cytometry 
prior to and after aerosol challenge with virulent Mycobacterium bovis. Polyfunctional
cytokine expression patterns in the response by Tcm, effector memory, and effector
T cell subsets were similar between BCG-vaccinated and M. bovis-infected calves, only 
differing in magnitude (i.e., infected > vaccinated). BCG vaccination, however, did alter 
the kinetics of the ensuing response to virulent M. bovis infection. Early after challenge 
(3  weeks post-infection), non-vaccinates had greater antigen-specific interferon-γ 
(IFN-γ)/tumor necrosis factor-α (TNF-α) and lesser IFN-γ/TNF-α/IL-2 responses by Tcm 
cells than did vaccinated animals. Importantly, these differences were also associated 
with mycobacterial burden upon necropsy. Polyfunctional responses to ESAT-6:CFP10 
(antigens not synthesized by BCG strains) were detected in memory subsets, as well
as in effector cells, as early as 3 weeks after challenge. These findings suggest that cell 
fate divergence may occur early after antigen priming in the response to bovine TB and 
that memory and effector T cells may expand concurrently during the initial phase of the 
immune response. In summary, robust IFN-γ/TNF-α response by Tcm cells is associated 
with greater mycobacterial burden, while IFN-γ/TNF-α/IL-2 response by Tcm cells are
indicative of a protective response to bovine TB.
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inTrODUcTiOn
Bovine tuberculosis (TB) is a chronic bacterial infection affect-
ing livestock, humans, and wildlife (1). Mycobacterium bovis, 
a member of the Mycobacterium tuberculosis complex, is the 
primary agent of TB in cattle, which causes substantial economic 
hardship for livestock producers. It is estimated that 50 million 
cattle are infected worldwide, costing approximately $3 billion 
annually to the livestock industry. In Great Britain alone, over 
300,000 cattle were slaughtered from 2003 to 2013 in an attempt 
to control the disease at a cost to taxpayers of £500 million (2). 
In addition to the socioeconomic ramifications of the disease, 
M. bovis poses a significant public health threat. The World 
Health Organization classifies bovine TB as one of the seven 
most neglected zoonotic diseases and as such, the disease is 
particularly devastating in resource poor settings due to limited 
regulatory control, consumption of non-pasteurized milk/ 
non-inspected meat, and co-morbidities affecting host suscepti-
bility and disease severity (3). In addition to both animal and 
public health significance, M. bovis infection in cattle is an excel-
lent model for human TB as adaptive immune responses and the 
ensuing immunopathogenesis are remarkably similar to that of 
M. tuberculosis infection in humans. Indeed, studies in cattle have 
been essential for the development of control strategies applicable 
to humans, such as the tuberculin skin test, interferon-γ (IFN-γ) 
release assays (IGRA), bacille Calmette–Guerin (BCG) vaccina-
tion, and approaches to differentiate infected from vaccinated 
individuals/animals (DIVA) [reviewed by Ref. (4)]. The study of 
human TB, including mouse and non-human primate models, 
has also led to considerable progress in the understanding and 
control of bovine TB.
Immunological memory is a primary feature of adaptive 
immunity and an essential goal of vaccination (5). In naïve 
hosts, effector and memory T cells are generated through 
developmental programing of naïve cells following an infection 
or antigen exposure. If infection is controlled, the vast majority 
of T cells generated during the expansion phase are eliminated 
and memory T cells remain, sometimes for a lifetime (6). Two 
major subsets of memory T cells (i.e., CD45RA−/CD45RO+) in 
humans and cattle are distinguishable based on expression of 
the lymphoid homing receptors CD62L and CCR7, reflecting 
important differences in function. Central memory T cells 
(Tcm) express CD62L and CCR7, are long-lived, and home to 
lymphoid tissues, while effector memory T cells (Tem) lack 
CCR7 and express minimal to no CD62L (6). In humans, 
Tcm cells exhibit elevated interleukin 2 (IL-2) production 
and proliferation potential, are long-lived, and able to generate 
heterogenic progeny capable of both terminal differentiation 
and self-renewal (7). Tcm cells are higher producers of effec-
tor molecules, such as IFN-γ, but exhibit low proliferation 
capability (6, 8, 9). In cattle, CD45RO+ CCR7+ memory cells 
in long-term cultures express high levels of CD62L (second-
ary lymphoid tissue homing receptor) and CD44 (homing cell 
adhesion molecule) and exhibit greater proliferation potential 
as compared to CD45RO+ CCR7− memory cells (10). While 
bovine CD45RO+ CCR7+ CD62Lhi memory cells (Tcm) are 
elicited by M. bovis infection, their role in the response to 
protective BCG vaccination has not been evaluated. However, 
long-term cultured IFN-γ ELISPOT assays (so called, cul-
tured IFN-γ ELISPOT) may be used as a surrogate of Tcm 
responses (8, 10–13). In cattle, cultured IFN-γ ELISPOT (i.e., 
10- to 14-day culture followed by overnight recall stimulation) 
responses to BCG ± subunit vaccines positively predict vaccine 
efficacy and duration of vaccine-induced protection (14–17). 
As with BCG vaccination of humans, protection provided by 
BCG in cattle varies widely (18, 19). In humans, cultured IFN-γ 
ELISPOT responses are detected in spontaneously cured TB 
subjects in the absence of ex vivo responses (i.e., overnight recall 
stimulation) (20). In contrast to the cultured IFN-γ ELISPOT, 
ex vivo assays detect primarily effector and Tem responses as a 
result of the brief stimulation period (i.e., 16–24 h) and rapid 
cytokine production (21–23).
Polyfunctional T cells simultaneously produce two or 
more cytokines with IFN-γ, IL-2, and tumor necrosis factor-α 
(TNF-α) being the most commonly measured (24, 25). 
Associations between protection and vaccination-induced 
polyfunctional T  cells have been mainly studied in small 
animal models (26–28). In humans, strong polyfunctional 
responses are detected in M. tuberculosis-infected individuals 
and are generally a sign of disease progression. Still, high 
IL-2 production is associated with a positive clinical status 
(e.g., latent or treated disease), while a strong IFN-γ/TNF-α 
response is associated with a failed response (i.e., active TB) 
(29). Human polyfunctional responses to vaccination both 
prior to TB exposure and in previously exposed individuals 
(i.e., latent infection) are extremely variable, much like BCG 
vaccination efficacy, and conflicting findings are reported (30, 
31). Furthermore, the relative lack of efficacious TB vaccines for 
humans hinders the clear assessment of correlates of protection, 
including that of polyfunctional T cells (26, 32–35). In cattle, 
T cell polyfunctionality has only been measured upon ex vivo 
recall stimulation (21, 36). These studies found no association 
between polyfunctional responses measured before challenge 
and vaccine success. However, polyfunctional responses to 
infection were associated with increased pathology and poor 
disease outcome (36). Polyfunctional responses by long-term 
cultured cells for enrichment of Tcm responses have not been 
evaluated in spite of the fact that cultured IFN-γ ELISPOT is one 
of the most promising protection correlates in cattle (14–17). 
Likewise, the discrimination of cell phenotype involved in 
cytokine production under both cultured and ex vivo condi-
tions may be necessary to identify specific correlates of vaccine 
efficacy, useful for the prioritization of vaccine candidates for 
costly biosafety level 3 (BSL-3) efficacy trials.
Early secretory antigenic target-6 (ESAT-6) and culture fil-
trate protein-10 (CFP-10) are co-secreted proteins encoded by 
the region of differentiation (RD)-1 of M. tuberculosis complex 
mycobacteria. Loss of the RD-1 region is the primary attenuat-
ing defect of BCG, and this region is absent in non-tuberculous 
mycobacterial (NTM) species (37–40). The differential expres-
sion of ESAT-6:CFP10 by tuberculous mycobacteria and their 
robust immunogenicity enables use of these antigens as a tool 
to discriminate M. bovis-infected from NTM-exposed or BCG-
vaccinated animals (41–45). Antigen 85A (Ag85A) and protein 
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TB10.4 are immunodominant antigens present in M. tuberculosis 
complex mycobacteria and BCG strains (1). M. bovis purified 
protein derivative (PPD) is a complex antigenic formulation, 
including many antigens also found in NTM. In the present 
study, the use of these antigens permitted assessment of both 
broad (PPD) and specific (TB10.4, Ag 85A) responses to vac-
cination and subsequent challenge, or exclusively to infection 
(ESAT-6:CFP10) (1).
Vaccine preparations included in the present study were BCG 
Danish (Statens Serum Institut, Copenhagen, Denmark, Strain 
1331) and a cocktail of four BCG Danish (Strain 1331) dele-
tion strains including BCG ΔfdrA, BCG ΔleuCD Δpks16, BCG 
ΔmetA, and BCG ΔmmaA4. BCG Danish is a widely used human 
pediatric vaccine to reduce human TB. Likewise, BCG Danish 
has been shown to reduce bovine TB disease burden in both 
experimental and field studies and has a well-established safety 
profile in cattle (1, 46, 47). The BCG Danish deletion derivatives 
used in this study are more attenuated and safer than the parental 
BCG strain in immunocompromised mice [(48, 49) and Berney-
Meyer et  al., unpublished data]. In immunocompetent mice, 
the BCG deletions Δfdr8, ΔmmaA4, and Δpks16 each result in 
enhanced mycobacterial immunogenicity through enhanced 
cross-presentation of mycobacterial antigens (Δfdr8), cytokine 
modulation (ΔmmaA4), and biofilm formation (Δpks16), as 
compared to the parental BCG [(48) and Berney-Meyer et  al., 
unpublished data]. BCG mutants, such as these, may also be 
used as vaccine vectors to promote epitope-specific responses 
(e.g., BCG Δpks12 for enhanced CD8 responses) (50). In the 
present study and as presented elsewhere (51), BCG Danish 
and the cocktail of BCG Danish deletions (hereafter called BCG 
mutants) were equally protective and induced similar IFN-γ- and 
Th17-associated cytokine responses, as evaluated in ex vivo assays 
for diagnostic purposes.
A better understanding of the cattle immune system may 
be beneficial to the understanding of both human and bovine 
TB, adding in the development of improved vaccine strategies 
in both species. Here, we investigated cytokine production (i.e., 
all combinations of IFN-γ, TNF-α, and IL-2) by flow cytometric 
analysis of memory T cell subsets in response to BCG vaccination 
and subsequent challenge with virulent M. bovis to determine 
how the elicited immune response correlated with infection 
outcome. Our findings indicate that early after infection, robust 
IFN-γ/TNF-α responses by Tcm are associated with greater 
mycobacterial burden, while IFN-γ/TNF-α/IL-2 responses by 
Tcm cells are indicative of a protective response.
MaTerials anD MeThODs
animal Use ethics and Biosafety
All studies were approved by the National Animal Disease Center 
Animal Care and Use and Institutional Biosafety committees 
and performed under appropriate project licenses within the 
conditions of the Animal Welfare Act. All animals were housed 
in appropriate biological containment facilities at the National 
Animal Disease Center. Given the low dose challenge and 
relatively short duration of the studies, animals did not develop 
clinical signs of bovine TB necessitating palliative therapy such 
as cough, dyspnea, anorexia, or weight loss. Strict biosafety pro-
tocols were followed to protect personnel from exposure to M. 
bovis throughout the study, including BSL-3 containment upon 
initiation of M. bovis challenge in animal rooms and standard 
BSL-3 laboratory practices for handling M. bovis cultures and 
samples from M. bovis-infected animals.
Mycobacterium bovis Vaccination and 
challenge Procedures
Holstein steers were obtained from bovine TB-free herds in IA, 
USA, and housed in a BSL-3 facility at the National Animal Disease 
Center, Ames, IA, USA. For the first experiment (study 1), animals 
were experimentally infected with 104 colony-forming units (cfu) 
of M. bovis 10-7428 (n = 8) by aerosol inoculation as described by 
(52). For the second study (study 2), calves were randomly assigned 
to the following treatment groups: no vaccination (n = 10), vac-
cination with M. bovis BCG Danish (Strain 1331; n =  9), and 
vaccination with a cocktail of four BCG Danish deletion strains 
including BCG Δfdr8, BCG ΔleuCD Δpks16, BCG ΔmmaA4 (48), 
and BCG ΔmetA (49) (n = 10). Vaccines (106 cfu, total dose) were 
administered subcutaneously at 2 weeks of age. Animals received 
M. bovis 10-7428 by aerosol (5 × 102 cfu) at 3.5 months of age (i.e., 
3 months after vaccination) as described by Palmer et al. (52).
Mycobacterial isolation and assessment 
of lesions
All calves were euthanized ~3.5  months after challenge with 
virulent M. bovis by intravenous administration of sodium 
pentobarbital. Tissues were examined for gross lesions and pro-
cessed for microscopic analysis and isolation of M. bovis. Tissues 
collected included lung; liver; and mandibular, parotid, medial 
retropharyngeal, mediastinal, tracheobronchial, hepatic, and 
mesenteric lymph nodes. Lymph nodes were sectioned at 0.5-cm 
intervals and examined. Each lung lobe was sectioned at 0.5- to 
1.0-cm intervals and examined separately. Lungs and lymph 
nodes (mediastinal and tracheobronchial) were evaluated using 
a semiquantitative gross pathology scoring system adapted from 
Vordermeier et al. (53). Tissues collected for microscopic analysis 
were fixed by immersion in 10% neutral buffered formalin. For 
microscopic examination, formalin-fixed tissues were processed 
by standard paraffin-embedment techniques, cut in 5-μm sec-
tions, and stained with hematoxylin and eosin. Adjacent sections 
from samples containing caseonecrotic granulomata suggestive 
of bovine TB were stained by the Ziehl–Neelsen technique for 
identification of acid-fast bacteria. Microscopic tuberculous 
lesions were staged (I–IV) based on a scoring system developed 
by Wangoo et al. (54).
long-Term and Ex Vivo cell culture
Peripheral blood mononuclear cells (PBMCs) were isolated from 
buffy coat fractions of blood collected by jugular venipuncture in 
2× acid citrate dextrose solution, using density gradient centrifu-
gation with Ficoll-Paque (Sigma, St. Louis, MO, USA). Complete 
RPMI medium for PBMC cell culture was RPMI 1640 (GIBCO, 
Grand Island) supplemented with 2-mM l-glutamine, 25-mM 
TaBle 1 | Primary and secondary monoclonal antibodies and staining 
reagents.
reagent specificity, source Fluorophore, source
ILA11 Bovine CD4, Washington 
State University
PE-Cy7, SouthernBiotech
ILA116 Bovine CD45RO, Washington 
State University
APC-Cy7, Life Technologies
7D12 Human CCR7 (CD197), BD 
Pharmingen
AF 350, Life Technologies or 
Spectral Red, SouthernBiotech
MCA1783-PE Bovine IFN-γ, AbD Serotec Not applicable
MCA2334-FITC Bovine TNF-α, 
BD Pharmingen
Not applicable
AbD14386-
DyLight649
Bovine IL-2,  
AbD Serotec
Not applicable
Live/dead  
staining
Pacific Blue, Life Technologies Not applicable
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HEPES buffer, 100 U/ml penicillin, 0.1 mg/ml streptomycin, 1% 
non-essential amino acids (Sigma), 2% essential amino acids 
(Sigma), 1% sodium pyruvate (Sigma), 50-mM 2-mercaptoetha-
nol (Sigma), and 10% (v/v) fetal bovine sera (FBS). Long-term 
cell cultures were generated by stimulating 2 ×  106/ml PBMC 
with a cocktail of M. bovis PPD (PPD, 5  μg/ml, Prionics Ag, 
Sclieren, Switzerland), Antigen85A (Ag85A – 1 μg/ml, LIONEX 
Diagnostics and Therapeutics GmbH, Braunschweig, Germany), 
TB10.4 (1  μg/ml, LIONEX Diagnostics and Therapeutics 
GmbH), and/or ESAT-6/CFP-10 (1 μg/ml, kind gift from Chris 
Minion, Iowa State University) in complete RPMI medium. Cells 
were cultured (2 × 106cells/well, 1 ml/well) in 24-well flat-bottom 
microtiter plates (Nunc, Thermo Fisher, Waltham, MA, USA) at 
39°C/5% CO2 for 13 days. The normal body temperature of cattle 
(Bos taurus) is 39°C and incubation of human blood at 39°C, as 
compared to 37°C, augments cytokine responses (55). Complete 
media containing human rIL-2 (Sigma, 10  U/ml) was used to 
replace media from the PBMC cultures at days 3 and 7. Fresh 
complete media without IL-2 was used at days 10 and 12.
At day 13, cultured cells were plated (2 ×  106 of cultured 
PBMC/well) into 96-well ELISPOT plates (Millipore, Watford, 
UK) and incubated in the presence of autologous antigen- 
presenting cells (APCs) and PPD (5  μg/ml), Ag85A/TB104 
(1 μg/ml of each protein), ESAT-6:CFP10 (1 μg/ml), pokeweed 
mitogen (PWM, Sigma) (1 μg/ml), or medium alone. Autologous 
APCs were isolated by adherence incubating 1 ×  105 freshly 
isolated PBMC in complete medium at 39°C/5% CO2 for 90 min 
in 96-well plates. Non-adherent cells were discarded, and the 
adherent cells (APCs) were washed four times with warm RPMI 
1640 media. Fresh complete media containing antigen and long-
term cultured cells were then incubated for 20  h at 39°C/5% 
CO2. Long-term cultured cells were then incubated for 16 h at 
39°C/5% CO2 with Brefeldin A (Sigma, 10 μg/ml) added at 4 h 
of culture.
For ex vivo culture, fresh PBMC isolated from buffy coat 
fractions of blood collected in 2× acid citrate dextrose solution 
were plated into 96-well plates (2 ×  105) and stimulated with 
PPD (5 μg/ml), Ag85A/TB104 (1 μg/ml of each protein), ESAT-
6:CFP10 (1 μg/ml), PWM (1 μg/ml), or medium alone for 16 h 
at 39°C/5% CO2 with Brefeldin A (Sigma, 10 μg/ml) added at 4 h 
of culture (56).
Flow cytometry
Following the appropriate culture duration, cells were pooled 
from individual animal replicates according to in vitro treatments 
(i.e., stimulation). Cells were stained as described by Whelan 
et al. (21) for assessment of bovine polyfunctional CD4 T cells 
and Maggioli et al. (10) for assessment of bovine memory/effector 
CD4 T cell subsets with antibodies listed in Table 1. Intracellular 
staining was performed following BD Perm/Wash instructions 
(BD Biosciences, San Jose, CA, USA). Flow cytometric analysis 
was performed with a BD LSR flow cytometer (BD Biosciences). 
Data were analyzed using FlowJo X (Tree Star Inc., San Carlos, 
CA, USA). A representative plot of the gating strategy is depicted 
in Figure S1 in Supplementary Material. A representative 
unstimulated condition response is depicted in Figure S2 in 
Supplementary Material.
statistical analysis
Data were analyzed using analysis of variance followed by 
Sidak’s  or Tukey’s multiple comparison test or Student’s t-test 
using GraphPAD Prism 6.0 (GraphPAD Software Inc., La Jolla, 
CA, USA).
resUlTs
M. bovis infection of cattle elicits 
specific Polyfunctional cytokine 
Production by cD4 T cells in  
long-Term and Ex Vivo cultures
Prior studies have demonstrated that M. bovis infection of cattle 
elicits polyfunctional CD4 T cell responses (21, 36); however, the 
relative contribution of effector, Tem, and Tcm subsets has not 
been evaluated. In the present study, individual cytokine (i.e., 
IFN-γ, TNF-α, and IL-2, Figures 1A,B) production by infected 
animals (study 1) did not differ between ex vivo or long-term cul-
tured cells in response to either PPD or ESAT-6:CFP10 stimula-
tion; however, the phenotype of responding cells greatly differed 
(P < 0.05) between culture conditions. In response to either PPD 
(Figure  1C) or ESAT-6:CFP10 (Figure  1D), Tcm cells (CD4+ 
CD45RO+ CCR7+) comprised ~80% of cytokine-producing 
cells in long-term cultures, while Tem (CD4+ CD45RO+ CCR7−) 
comprised ~60% of cytokine-producing cells in ex vivo cultures. 
Analysis of CD4 T cell cytokine profiles (i.e., all combinations 
of IFN-γ, TNF-α, and IL-2) revealed frequent coproduction of 
multiple cytokines under both ex vivo and long-term culture con-
ditions in response to either PPD or ESAT-6:CFP10 by M. bovis-
infected cattle (Table 2). IFN-γ/TNF-α and IFN-γ/TNF-α/IL-2 
co-production were the predominant (P < 0.05) polyfunctional 
cytokine profile, regardless of culture condition. Also, long-term 
and ex vivo polyfunctional responses to either PPD or ESAT-
6:CFP10 were comparable (i.e., comparison between the same 
profile under either ex vivo or long-term culture; P > 0.05) for 
all seven possible cytokine profiles (Table 2). As with the analysis 
of individual cytokine production, Tcm was the main phenotype 
contributing to polyfunctional responses in long-term cultures, 
whereas Tem was the main subset producing cytokines in ex vivo 
cultures (Figure 2).
FigUre 1 | individual cytokines produced by different effector/memory phenotypes based upon culture conditions. For long-term cultures, PBMCs from 
infected calves were isolated and stimulated with a cocktail of Ag85A, TB10.4, and ESAT-6:CFP10 as well as PPD for 13 days followed by transfer to 96-well round 
bottom plates with APCs and addition of media alone, PPD, or ESAT-6:CFP10 for an additional 16 h. For ex vivo culture, PBMCs were stimulated with media alone, 
PPD or ESAT-6:CFP10 for 16 h. Cytokine production and effector/memory phenotype were determined by ICS flow cytometry. Results are presented as average 
and SE for responses over the course of the study (n = 5 animals, 3 time points). Frequency long-term (closed bars) and ex vivo (open bars) cultured CD4 T cells 
producing IFN-γ, TNF-α, or IL-2 in response to PPD (a) or ESAT-6:CFP10 (B). Phenotype of long-term (closed bars) and ex vivo (open bars) CD4 T cells producing 
any combination of IFN-γ, TNF-α, or IL-2 in response to PPD (c) or ESAT-6:CFP10 (D) based on CD45RO and CCR7 expression (Figure S1 in Supplementary 
Material). *Responses from PBMCs differ (P < 0.05, Sidak’s) between long-term and ex vivo cultures.
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Vaccine efficacy
Three and half months after vaccination (study 2), animals 
received virulent M. bovis by aerosol. Vaccine efficacy was assessed 
upon necropsy at 4.5 months after challenge. BCG mutants and 
BCG vaccinates had reduced bacterial load (Figure 3A, P < 0.05) 
and gross pathology as compared to non-vaccinates (Figure 3B, 
P < 0.05). Mean disease scores and M. bovis colonization did not 
differ between BCG mutants and BCG vaccinates. Lesion stag-
ing by histology corroborated gross lesion results (Figure 3C). 
Noteworthy, only non-vaccinated calves developed stage IV 
granulomas that generally contain large numbers of acid-fast 
bacilli (57), likely associated with increased transmission. In 
summary, both vaccines were exquisitely protective, decreasing 
pathology and bacterial burden.
cytokine responses elicited by 
Bcg Vaccination
Vaccination of calves with either BCG or BCG mutants (study 2) 
elicited specific cytokine production at 6 weeks post-vaccination 
(WPV) in response to Ag85A/TB10.4 (Figure  4) and PPD 
(Figure S3 in Supplementary Material). As expected for this time 
point prior to M. bovis infection, non-vaccinated calves showed 
minimal or no responses to mycobacterial antigens. Long-term 
culture responses by vaccinated calves, as measured by IFN-γ, 
TNF-α, and IL-2, were generally higher (P  <  0.05) than the 
respective ex vivo responses (Figure 4). As observed in infected 
calves (study 1), the proportion of Tcm, Tem, and effector cells 
contributing to cytokine production in response to PPD and 
Ag85A/TB10.4 differed between long-term and ex vivo cultures 
TaBle 2 | iFn-γ/TnF-α/il-2 and iFn-γ/TnF-α are the predominant 
polyfunctional profile in response to M. bovis infection, as assessed by 
long-term and ex vivo assays.
cytokine profilec PPD esaT6:cFP10
long-term 
average 
(seM)
Ex vivo 
average 
(seM)
long-term 
average  
(seM)
Ex vivo 
average 
(seM)
IFN-γ/TNF-α/IL-2 3.92 (0.55)a 4.03 (0.78)a 4.51 (0.64)a 3.79 (0.71)a
IFN-γ/TNF-α 4.44 (0.51)a 4.69 (0.59)a 5.37 (0.59)a 4.32 (0.70)a
IFN-γ/IL-2 1.31 (0.09)b 1.26 (0.22)b 1.01 (0.36)b 1.18 (0.24)b
TNF-α/IL-2 2.02 (0.24)b 2.09 (0.24)b 1.39 (0.14)b 2.06 (0.30)b
IFN-γ 1.15 (0.12)b 1.27 (0.35)b 0.86 (0.13)b 1.28 (0.41)b
TNF-α 0.31 (0.05)b 1.08 (0.23)b 0.20 (0.06)b 1.15 (0.28)b
IL-2 0.98 (0.36)b 1.83 (0.29)b 1.48 (0.35)b 1.79 (0.34)b
a,bDifferent letters indicate differences (P < 0.05) in the frequency of profiles within each 
culture condition (long-term or ex vivo). Differences in polyfunctional profile frequencies 
between long-term and ex vivo were not detected (P > 0.05, Tukey’s).
cData are presented as frequencies (%) of cytokine-producing cells within long-term 
or ex vivo cultures.
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(Figure 5, P < 0.05). Responding cells in long-term cultures most 
frequently exhibited a Tcm phenotype, while ex vivo cytokine 
production was mainly due to Tem cells. The contribution of 
naïve cells to the cytokine response was minimal and did not 
differ based on vaccination or culture conditions. Cell phenotype 
(Tcm, Tem, and effector) and polyfunctional profiles within long-
term or ex vivo cultures did not differ between BCG mutants and 
BCG vaccinates to Ag85A/TB10.4 (Figure S4 in Supplementary 
Material) nor PPD (Figure S5 in Supplementary Material) at 
6 WPV. Vaccine-elicited polyfunctional responses were detected 
to PPD and Ag85A/TB10.4 but not to ESAT-6:CFP10 (Figure 6). 
Thus, BCG vaccination elicits a specific polyfunctional CD4 
T  cell response and the culture duration (long-term versus ex 
vivo) dictates whether the response is primarily within Tcm or 
Tem subsets, respectively. These findings also confirm that long-
term cultured ELISPOT responses associated with protection to 
subsequent M. bovis infection in cattle are primarily a measure of 
CD4 Tcm responses (14, 58).
lower iFn-γ/TnF-α and higher iFn-γ/
TnF-α/il-2 coproduction by Tcms early 
after infection by Vaccinates as compared 
to non-Vaccinates
Early after challenge with virulent M. bovis [3  weeks post- 
infection (WPI)], non-vaccinates had greater (P < 0.05) IFN-γ/
TNF-α responses to PPD, Ag85A/TB10.4, and ESAT-6:CFP10 by 
Tcm cells than did vaccinated animals (Figure 7). This difference 
was surprising given that vaccination elicited IFN-γ/TNF-α 
responses to PPD as well as Ag85A/TB10.4; and one might antici-
pate that these responses would be boosted after challenge with 
virulent M. bovis. In contrast, the IFN-γ/TNF-α/IL-2 response 
by vaccinates exceeded (P <  0.05) the respective response by 
non-vaccinates early after challenge (Figure  7). As with post- 
vaccination responses, responses by BCG mutants and BCG 
vaccinates did not differ at 3 WPI (Figure S5 in Supplementary 
Material) and 8  WPI (data not shown). Also, polyfunctional 
responses by Tcm cells at 8 WPI were similar among vaccinates 
and non-vaccinates (Figure  8). To investigate how vaccination 
and infection-elicited responses contrast, we compared the 
polyfunctional cytokine response by vaccinates at 6  WPV to 
that of non-vaccinates at 3 and 8  WPI. At 8  WPI, long-term 
and ex vivo responses to infection exceeded (P < 0.05) respec-
tive responses to vaccination for most polyfunctional profiles 
to both Ag85A/TB10.4 and PPD (Figure S7 in Supplementary 
Material). Importantly, both IFN-γ/TNF-α/IL-2 and IFN-γ/TNF-
α responses to infection at 3 WPI (data not shown) and 8 WPI 
(Figure S7 in Supplementary Material) exceeded (P  <  0.05) 
respective responses to vaccination upon recall stimulation of 
long-term cultures with Ag85A/TB10.4. Thus, both attenuated 
and virulent strains of M. bovis elicit polyfunctional T cell 
responses; however, these responses differ in magnitude.
The most striking difference between vaccinates and non-
vaccinates was the relative contribution of IFN-γ/TNF-α/IL-2 
and TNF-α/IFN-γ production by Tcm cells early after challenge 
(3 WPI). The kinetics of long-term culture Tcm cells expressing 
these polyfunctional profiles is depicted in Figure 9. Vaccination 
elicited IFN-γ/TNF-α/IL-2 and IFN-γ/TNF-α polyfunctional 
Tcm responses to Ag85A/TB10.4 but not to ESAT-6:CFP10. 
Three weeks after challenge, IFN-γ/TNF-α responses by Tcm 
cells were greater in non-vaccinates as compared to vaccinates 
(Figure 9, P < 0.05), while vaccinates maintained higher percent-
ages of IFN-γ/TNF-α/IL-2-producing Tcm cells in comparison to 
non-vaccinates (Figure 9, P < 0.05). At 8 weeks post-challenge, 
TNF-α/IFN-γ/IL-2 and TNF-α/IFN-γ responses were similar 
between vaccinates and non-vaccinates (Figure  9). Thus, BCG 
vaccination alters the ensuing polyfunctional profile upon infec-
tion with virulent M. bovis, favoring early IFN-γ/TNF-α/IL-2 
production by CD4+ Tcm cells and dampening TNF-α/IFN-γ 
elicited by infection.
Vaccination-elicited Protection is 
associated with reduced iFn-γ/TnF-α 
responses by Tcm cells early after 
challenge
After M. bovis challenge, Th-1 responses to mycobacterial 
antigens generally correlate with TB-associated pathology and 
poor vaccine efficacy (15, 53, 58, 59). In our study, both vaccines 
provided a high level of protection. M. bovis was isolated from 
only five vaccinated animals (four BCG mutants and one BCG 
vaccinate). Retrospective analysis comparing responses to early 
infection (3 WPI) by non-vaccinates versus culture-negative vac-
cinates (n = 14) or culture-positive vaccinates (n = 5) revealed 
differential IFN-γ/TNF-α responses by Tcm cells to ESAT-
6:CFP10 among the groups (Figure 10A, P < 0.05). IFN-γ/TNF-α 
responses by Tcm cells from non-vaccinates were higher than 
that of both M. bovis culture-negative and -positive vaccinates 
(Figure  10A, P  >  0.05). M. bovis culture-positive vaccinates 
produced intermediate cytokine levels, while culture-negative 
animals had the lowest IFN-γ/TNF-α responses (Figure  10A, 
P <  0.05). Conversely, IFN-γ/TNF-α/IL-2 production by Tcm 
cells was higher in culture-negative vaccinates as compared to 
culture-positive non-vaccinates (Figure 10B, P > 0.05). IFN-γ/
TNF-α/IL-2 responses by Tcm cells from culture-positive 
FigUre 2 | Polyfunctional profiles by effector/memory phenotypes differ based on culture conditions. For long-term culture, PBMCs were isolated and 
stimulated with a cocktail of Ag85A, TB10.4, and ESAT-6:CFP10 as well as PPD for 13 days followed by transfer to 96-well round bottom plates with APCs and 
addition of media alone, PPD, or ESAT-6:CFP10 for an additional 16 h. For ex vivo culture, PBMC were stimulated with media alone, PPD, or ESAT-6:CFP10 for 
16 h. Cytokine production and effector/memory phenotype were determined by ICS flow cytometry. Results are presented as average and SE for responses over 
the course of the study (n = 30, 5 animals × 3 time points). Percentages of polyfunctional profiles in response to long-term stimulation with PPD (a) or ESAT-
6:CFP10 (B) or ex vivo stimulation with PPD (c) or ESAT-6:CFP10 (D) split by effector/memory phenotype based on CD45RO and CCR7 expression (Figure S1 in 
Supplementary Material). *Responses differ (P < 0.05, Tukey’s) from the other two phenotypes. a,b,cDifferent letters indicate differences (P < 0.05, Tukey’s) in effector/
memory phenotypes within a particular polyfunctional subset.
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vaccinates were intermediate, not differing from either culture-
negative vaccinates or non-vaccinates (Figure  10B, P <  0.05). 
IFN-γ/TNF-α/IL-2 and IFN-γ/TNF-α production by Tcm cells 
in ex vivo assays did not differ among culture-negative and 
culture-positive animals (Figures 10C,D, P > 0.05). Thus, these 
results indicate that strong IFN-γ/TNF-α responses by Tcm cells 
are associated with greater mycobacterial burden, while IFN-γ/
TNF-α/IL-2 responses by Tcm cells are indicative of a protective 
response provided by vaccination.
DiscUssiOn
Tuberculosis in cattle shares many features with TB in humans, 
and studies with neonatal calves are particularly pertinent to 
human TB, since children are the primary target population for 
vaccination with exposure to TB often occurring at a very young 
age (1). Also, in contrast to laboratory mice, cattle are out-bred; 
thus, experimental variance is more similar to that of humans and 
of relevance for evaluation of safety and efficacy of vaccines, adju-
vants, or other administered biologics. This can have significant 
advantages for a translational understanding of the mechanisms 
of pathogenesis and, more importantly, immunity. While cor-
relates of vaccine-induced protection against TB are not entirely 
understood, Tcm cells are presumed to be critical for protection 
in cattle and humans (1, 13, 18, 20, 29, 32). Likewise, the role of 
polyfunctional CD4 T cells in the immune response to TB is not 
well established. Here, we have shown that two protective BCG 
vaccine formulations elicited similar polyfunctional responses 
in vaccinated calves, and that early upon challenge with virulent 
M. bovis, responses by protected animals exhibited a different 
profile of response by Tcm cells as compared to that of unpro-
tected animals. Protected vaccinates had a lower frequency of 
FigUre 4 | long-term and ex vivo cytokine responses to vaccination. For long-term culture, PBMCs were isolated at 6 WPV and stimulated with a cocktail of 
Ag85A, TB10.4, and PPD for 13 days followed by transfer to 96-well round bottom plates with APCs and addition of media alone or Ag85A/TB10.4 for an additional 
16 h. Results are presented as average and SE. Frequency of long-term (left) and ex vivo (right) cultured CD4 T cells producing IFN-γ (a), TNF-α (B), and IL-2 (c). 
*a,b,cDifferent letters indicate significant differences (P < 0.05) in cytokine production in long-term and ex vivo culture condition (Tukey’s).
FigUre 3 | Bcg mutants and Bcg vaccination confers protection against virulent M. bovis challenge. (a) Quantitative assessment of mycobacterial 
burden in tracheobronchial lymph nodes. (B) Total gross pathology scores from lung and tracheobronchial and mediastinal lymph nodes. (c) Data are presented as 
average number of stages I–IV microscopic lesions observed in mediastinal lymph nodes, tracheobronchial lymph nodes, and lung based on the scoring system 
developed by Wangoo et al. (54). *Parameters differ (P < 0.05, Tukey’s) between non-vaccinates (n = 10) and BCG mutants (n = 10) or BCG vaccinates (n = 9).
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FigUre 5 | Vaccine-elicited cytokine production is due to different effector/memory phenotypes based upon culture conditions. For long-term culture, 
PBMCs were isolated at 6 WPV and stimulated with a cocktail of Ag85A, TB10.4, and PPD for 13 days followed by transfer to 96-well round bottom plates with 
APCs and addition of media alone PPD (a) or Ag85A/TB10.4 (B) for an additional 16 h. Cytokine production and effector/memory phenotype were determined by 
ICS flow cytometry. Results are presented as average and SE. Frequency of cytokine-producing cells under long-term or ex vivo culture exhibiting Tcm, Tem, 
effector, or naïve phenotype using the gating strategy described in Figure S1 in Supplementary Material. *Differences (P < 0.05) in cytokine production within 
memory subsets (i.e., Tcm, Tem, effector, or naïve) in long-term as compared to ex vivo cultures (Tukey’s).
9
Maggioli et al. Memory Polyfunctionality in Bovine Tuberculosis
Frontiers in Immunology | www.frontiersin.org October 2016 | Volume 7 | Article 421
ESAT-6:CFP10-specific Tcm cells coproducing IFN-γ and TNF-
α, suggesting that the incitement of strong Tcm IFN-γ/TNF-α 
responses early upon infection is related to a higher bacterial 
burden and inability of the host to control mycobacterial growth. 
On the other hand, higher frequencies of Tcm cells producing 
IFN-γ/TNF-α/IL-2 early after infection were associated with 
vaccine-elicited protection and bacterial arrest by the host.
Polyfunctional cytokine responses were detected upon 
antigenic stimulation of freshly isolated and long-term cultured 
PBMCs with no difference in the percentages of cytokine-
producing cells based on culture condition. Still, the phenotype 
of responding cells greatly differed, with enriched numbers of 
responding Tcm cells in long-term culture and Tem cells in ex 
vivo cultures. This finding is consistent with previous research 
evaluating the phenotype of antigen-specific cytokine-producing 
cells in long-term cultures in humans (8, 11, 12) and cattle (10). 
As previously detected in naturally infected cattle, experimental 
infection-elicited polyfunctional responses biased toward IFN-
γ/TNF-α and IFN-γ/TNF-α/IL-2 profiles (21). In response to 
vaccination, long-term cultured PBMC responses were generally 
higher than that of ex vivo stimulated PBMCs. Long-term culture 
has been used as a method to improve the sensitivity of TB diag-
nostic tests for humans (60, 61), so it is reasonable to speculate 
that long-term culture enriches low frequency antigen-specific 
cells, as with vaccination, consequently aiding in response 
detection.
As early as 3  WPI, IFN-γ/TNF-α responses by both Tcm 
and Tem cells (i.e., in long-term cultured and ex vivo assays, 
respectively) from non-vaccinates exceeded that of vaccinates. 
Yet, whether detection of Tcm responses in in vitro cultures so 
early upon infection was a consequence of in vitro conditions or 
whether antigen-specific cells, or their progeny, maintained their 
true phenotype throughout the in vitro culture requires further 
investigation. Studies have shown that the antigen specificity 
of responding cells in ex vivo and cultured ELISPOT assays do 
not necessarily correlate to each other with HIV (62), EBV (63), 
hepatitis C virus (11), or malaria infection (64, 65), demonstrat-
ing that the nature of the response by cytokine-producing cells 
FigUre 6 | specific Tcm responses to vaccination at 6 weeks post-vaccination. For long-term culture, PBMCs were isolated at 6 WPV and stimulated with 
a cocktail of Ag85A, TB10.4, and PPD for 13 days followed by transfer to 96-well round bottom plates with APCs and addition of media alone, PPD, Ag85A/
TB10.4, or ESAT-6:CFP10 for an additional 16 h. Cytokine production and effector/memory phenotype were determined by ICS flow cytometry. Results are 
presented as average and SE. Polyfunctional responses by Tcm cells (gated on CD45RO+/CCR7+/CD4+ cells) were detected upon recall stimulation with PPD (a), 
Ag85A/TB10.4 (B), but not to ESAT-6:CFP10 (c). *Different (P < 0.05, Tukey’s) responses between non-vaccinates and both vaccinated groups.
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may differ based on culture conditions. Likewise, it could be 
argued that the stimulation protocol might have induced in vitro 
priming of naïve T cells. In vitro priming, however, is unlikely due 
to the relatively short duration of the assay, absence of peptide 
antigen stimulation during the initial 13-day culture phase, no 
addition of cytokines apart from IL-2, and no enrichment of 
dendritic cells – all of which are required for in vitro priming (66). 
The absence of response to vaccine antigens by non-vaccinates 
FigUre 7 | higher iFn-γ/TnF-α and lower iFn-γ/TnF-α/il-2 Tcm responses by non-vaccinates versus vaccinates at 3 weeks post-challenge. For 
long-term culture, PBMCs were isolated at 3 WPI and stimulated with a cocktail of Ag85A, TB10.4, and PPD for 13 days followed by transfer to 96-well round 
bottom plates with APCs and addition of media alone, PPD, Ag85A/TB10.4, or ESAT-6:CFP10 for an additional 16 h. Cytokine production and effector/memory 
phenotype were determined by ICS flow cytometry. Results are presented as average and SE. Polyfunctional responses by Tcm cells (gated on CD45RO+/CCR7+/
CD4+ cells) were detected upon recall stimulation with PPD (a), Ag85A/TB10.4 (B), or ESAT-6:CFP10 (c). *Parameters differ (P < 0.05, Tukey’s) in cytokine 
production by vaccinates versus non-vaccinates.
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prior to challenge further supports the notion that priming of 
naïve cells occurs in vivo and not as a consequence of long-term 
culture. Moreover, IFN-γ responses to vaccination in long-term 
cultures are associated with protection upon M. bovis challenge, 
indicating that the assessed in vitro response does hold a connec-
tion to the in vivo outcome.
FigUre 8 | By 8 weeks post-M. bovis challenge, polyfunctional responses by Tcm cells did not differ between vaccinates and non-vaccinates. For 
long-term culture, PBMCs were isolated at 8 WPI and stimulated with a cocktail of Ag85A, TB10.4, and PPD for 13 days followed by transfer to 96-well round bottom 
plates with APCs and addition of media alone, PPD, Ag85A/TB10.4, or ESAT-6:CFP10 for an additional 16 h. Cytokine production and effector/memory phenotype 
were determined by ICS flow cytometry. Results are presented as average and SE. Polyfunctional responses by Tcm cells (gated on CD45RO+/CCR7+/CD4+ cells) upon 
recall stimulation with PPD (a), Ag85A/TB10.4 (B), or ESAT-6:CFP10 (c). *Differences (P < 0.05, Tukey’s) in cytokine production by vaccinates versus non-vaccinates.
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Polyfunctional responses to ESAT-6:CFP10 (antigens not 
synthesized by BCG strains) were detected in effector, Tem, 
and Tcm populations from BCG vaccinates early after challenge 
(3 WPI). This finding is consistent with the early asymmetric divi-
sion model of maturation, indicating memory and effector T cells 
expand concomitantly during the effector phase of the response 
and relatively early upon infection (67–72). In the mouse model, 
BCG elicited Tcm cells are detected as early as 20  days after 
vaccination and correlate with improved T cell recruitment to 
the lung. Also, the adoptive transfer of Tcm, but not Tem cells, is 
sufficient to confer protection (5). Laouar et al. (68) demonstrated 
the appearance of CD8 memory cells during the acute phase of 
FigUre 9 | Kinetics of iFn-γ TnF-α il-2 and iFn-γ TnF-α responses by Tcm. For long-term culture, PBMCs isolated at 6 weeks post-vaccination (6 WPV), 
3 weeks post-infection (3 WPI) and 8 WPI were stimulated with a cocktail of Ag85A, TB10.4, and PPD for 13 days followed by transfer to 96-well round bottom 
plates with APCs and addition of media alone, Ag85A/TB10.4 or ESAT-6:CFP10 for an additional 16 h. Cytokine production and effector/memory phenotype were 
determined by ICS flow cytometry. Results are presented as average and SE. Percentages of long-term cultured Tcm cells (gated on CD45RO+/CCR7+/CD4+ cells) 
producing IFN-γ/TNF-α/IL-2 or IFN-γ/TNF-α upon recall stimulation with Ag85A/TB10.4 (a,B) or ESAT-6:CFP10 (c,D). *Differences (P < 0.05, Tukey’s) in the 
cytokine production by non-vaccinates and vaccinates.
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a primary response to lymphocytic choriomeningitis virus as 
early as 8 days after infection. Likewise, prime-boost vaccination 
with viral-vectored vaccines expressing malarial antigens induce 
both ex vivo and cultured IFN-γ ELISPOT responses by 7 days 
after boost (65). It is important to note that antigen clearance 
appears to have a crucial role on the kinetics of the response, and 
pathogen clearance in chronic infections, such as TB (including 
M. bovis infection in calves), is not always achieved. Moreover, 
the very factors governing effector/memory T cell differentia-
tion remain largely unknown. Whether memory cells arise (a) 
as direct progenies of effector cells [linear differentiation model 
(73–75)], (b) via a linear process dictated by a progressive loss 
of T cell differentiation potential (i.e., from naïve  →  effec-
tor → memory → terminally differentiated cells) dependent on 
antigenic stimulation and signaling milieu [decreasing potential 
model (76, 77)], or (c) as a separate lineage from naïve cells 
[divergent differentiation model (67, 69)] has long been debated. 
Still, the connection between naïve CD4 T cells and the various 
effector and memory fates these cells follow remains elusive, and 
a single unifying theory accounting for the diversity of CD4 T cell 
memory has not been discovered (78, 79). This fact suggests that 
various mechanisms of CD4 T cell memory generation may be 
differentially engaged depending on various factors (e.g., level of 
inflammation) and that these models are not necessarily mutu-
ally exclusive. Still, cell fate divergence (i.e., asymmetric division) 
early after priming has been reported by several authors (5, 65, 
67–69) and is supported by the present findings, suggesting that 
memory generation begins prior to antigen clearance.
Early upon infection, vaccinates exhibited higher numbers 
of antigen-specific IFN-γ/TNF-α/IL-2 Tcm cells than did non-
vaccinates, and such dissimilar responses between vaccinates 
and non-vaccinates early after challenge is associated with 
disease outcome. Polyfunctionality is often associated with less 
differentiated T cells (Tcm and Tem, as opposed to terminally 
differentiated T cells expressing killer cell lectin-like receptor 1 – 
KLRG1) and better quality of responses (32, 76, 79). Persistent or 
prolonged antigen stimulation is related to a progressive loss of 
central memory T cell pool, resulting in unfit immune responses 
by terminally differentiated, short-lived cells that produce single 
cytokine or loss of effector function all together (32, 80). The 
higher numbers of IFN-γ/TNF-α/IL-2 Tcm cells may indicate 
that vaccinated calves were able to control antigen load, retaining 
FigUre 10 | iFn-γ/TnF-α/il-2 and iFn-γ/TnF-α polyfunctional responses at 3 weeks post-infection by Tcm, but not by Tem cells, differ based upon 
M. bovis colonization and vaccination status. Calves were grouped accordingly with both vaccine status and bacterial burden results (culture positive or 
negative) for assessment of IFN-γ/TNF-α/IL-2 and IFN-γ/TNF-α Tcm response by flow cytometry at 3 WPI. Long-term culture consisted of PBMCs isolated at 3 WPI 
and stimulated with a cocktail of Ag85A, TB10.4, and PPD for 13 days followed by transfer to 96-well round bottom plates with APCs and addition of media alone 
or ESAT-6:CFP10 for an additional 16 h. Results are presented as average and SE. IFN-γ/TNF-α and IFN-γ/TNF-α/IL-2 polyfunctional responses by Tcm cells (gated 
on CD45RO+/CCR7+/CD4+ cells) from vaccinates (either culture positive or negative) or non-vaccinates upon recall stimulation with ESAT-6:CFP10 (a,B). IFN-γ/
TNF-α and IFN-γ/TNF-α/IL-2 polyfunctional responses by Tem cells (gated on CD45RO+/CCR7−/CD4+ cells) vaccinates (either culture positive or negative) or 
non-vaccinates upon recall stimulation with ESAT-6:CFP10 (c,D). a,b,cDifferent letters indicate differences (P < 0.05, Tukey’s) in cytokine production among 
vaccinates (culture positive and negative) and non-vaccinates. *Differences (P < 0.05, Tukey’s) in the cytokine production between culture-negative vaccinates and 
non-vaccinates.
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greater levels of cell functionality, which was beneficial in the 
long run. In future studies, we will evaluate KLRG1 expression 
on CD4 T cell effector/memory populations with the various 
polyfunctional profiles over a longer course of M. bovis infection 
to determine KLRG1 association with the expression of effector 
function by T cells in cattle.
As both vaccine treatments were proven to be exceptionally 
protective, we investigated whether vaccinated animals with no 
detectable M. bovis by quantitative culture responded to infection 
differently than did vaccinated animals with detectable M. bovis 
and/or non-vaccinates (all of which had detectable M. bovis by 
quantitative culture). Surprisingly, IFN-γ/TNF-α responses by 
Tcm cells differed among all three groups, suggesting coloniza-
tion, and perhaps antigen load, could be associated with the 
number of IFN-γ/TNF-α antigen-specific cells. Intriguingly, 
similar numbers of Tcm cells producing IFN-γ/TNF-α/IL-2 were 
detected in vaccinates, regardless of their culture status. Still, IFN-
γ/TNF-α/IL-2 responses were greater in vaccinates as compared to 
non-vaccinates, indicating that vaccine-induced IFN-γ/TNF-α/
IL-2 responses may be associated with protection. Also, low level 
of TB-associated pathology was present in a few vaccinates with 
no detectable M. bovis by quantitative culture. It is known that 
few bacilli are required to cause TB-associated pathology, and the 
vaccine may have reduced the bacterial burden below the limit of 
M. bovis detection. Interestingly, three vaccinates with detectable 
M. bovis by quantitative culture showed no TB-associated pathol-
ogy (lung and lung-associated lymph nodes). It is possible that 
TB-associated pathology was only delayed by vaccination, and 
these animals would still progress to clinical disease. It also indi-
cates that even though vaccinates with detectable M. bovis had 
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higher numbers of Tcm producing IFN-γ/TNF-α as compared 
to vaccinates with no M. bovis, the moderate levels of IFN-γ/
TNF-α/IL-2 (or a combination of factors) would have conferred, 
if not a sterilizing protection, a significant decrease/delay in 
TB-associated pathology even in the presence of the pathogenic 
bacilli. This scenario would still be beneficial to the host.
Central memory T cells expressing IL-2 are associated with 
latent TB or effective anti-mycobacterial therapy in humans, 
whereas patients with active TB predominately exhibit effector 
cells that express IFN-γ/TNF-α (34, 81, 82). This suggests that 
CD4 T cell functional capacity is driven toward terminally dif-
ferentiated T cells by bacterial load and continuous antigen expo-
sure (34). While the occurrence of latency is not well established 
in cattle, non-vaccinates and non-protected vaccinates exhibited 
higher IFN-γ/TNF-α responses by Tcm cells than did protected 
calves early after challenge, similar to what occurs with active 
disease in humans. Additionally, protected vaccinates exhibited 
higher numbers of IFN-γ/TNF-α/IL-2-producing Tcm cells. It is 
plausible that the amount of initial antigen exposure controls the 
extent of differentiation and that vaccinated animals were more 
capable of containing the infection initially, preventing the loss 
of CD4 polyfunctional capacity. Moreover, single IL-2 produc-
ers did not differ among vaccinates and non-vaccinates or vary 
dependent upon M. bovis culture status at necropsy, which may 
indicate that the polyfunctional capacity, and not IL-2 produc-
tion per se, was the most relevant protective response assessed. 
Such responses could be either a surrogate of other protective 
mechanisms or a just an indication of immune response fitness 
(e.g., the presence of Tcm exhibiting plasticity, more prone to 
long-term survival, or producing other cytokines). Protection 
to TB may require different levels of Tcm and Tem memory 
responses and also different ratios of Tcm to Tem in the differ-
ent phases of this chronic infection (83). It is also possible that 
the presence of Tcm cells producing IFN-γ/TNF-α/IL-2 was a 
consequence of lower bacterial burden, rather than its cause. 
Importantly, Sakai et al. (84) demonstrated in the mouse model 
that differentiated T cells expressing KLRG1 elicited by BCG 
vaccination are retained within lung blood vasculature, lacking 
the ability to migrate into the lung parenchyma. Although these 
cells may produce high levels of IFN-γ, they are still functionally 
impaired and unable to confer protection in the lung. Kaushal 
et al. (85) showed that aerosol immunization of macaques with 
an MtbΔsigH mutant was highly protective against an otherwise 
lethal M. tuberculosis aerosol challenge. MtbΔsigH vaccinated 
macaques exhibited higher numbers of Tcm cells in response to 
vaccination (as compared with BCG or non-vaccinated controls) 
and higher percentages of IFN-γ/TNF-α/IL-2 in their lungs after 
challenge. The assessment of T cell survival, senescence, and 
peripheral migration markers [e.g., B-cell lymphoma 2 protein 
(BCL-2), KLRG-1, and programed cell death protein 1 (PD-1)], 
local responses in the lungs, as well the measure of a broader panel 
of cytokines would further the understanding of our findings, but 
such analyses were not achievable in the present experiments.
Predicting vaccine efficacy is difficult, in part, due to the lack 
of consistent immunological correlates of protection, especially 
one that would be appropriate throughout the different stages of 
chronic infections. Effective responses are likely not static, with 
different subsets displaying a variety of functions and migration 
capabilities necessary for disease prevention, bacterial arrest, and 
infection resolution. Recently, Ziraldo et al. (83) proposed a com-
putational model to explore Tem and Tcm responses to a variety 
of mycobacterial antigens, generating a tool to predict vaccine 
formulations that would provide protective ratios of memory 
cells with desirable functionalities. If this approach proves to be 
successful, it would offer further insights into protection cor-
relates and vaccination strategies to accomplish protection. In 
the meantime, present findings indicate that IFN-γ/TNF-α and 
IFN-γ/TNF-α/IL-2 responses by Tcm cells early after M. bovis 
infection in cattle are associated with detrimental and protective 
outcomes, respectively.
In summary, determining the T cell responses by measuring 
their functionality in combination with cell surface phenotype 
is likely to increase the fundamental understanding of T cell 
memory and effector differentiation, as these parameters define 
the T cell functional capacity, life-span potentials, antigen expo-
sure history, and trafficking capabilities. Thus, phenotypic and 
functional analysis of T cells offers an assessment of the quality 
of the immune response, allowing a clearer evaluation of whether 
and how a response is protective, than either of these parameters 
measurement alone.
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